Skip to content

Trial Summary

This study aims to assess the efficacy and clinical outcomes of Stereotactic Body Radiotherapy (SBRT) with the standard of care (SOC) which may include percutaneous ablation (PA), transarterial chemoembolization (TACE), transarterial embolisation (TAE) or transarterial radioembolisation (TARE) in patients with early hepatocellular carcinoma.



ACTRN/NCT /ethics:


Scientific title:

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)

Sponsor / Cooperative group:

Medical Research Future Fund (MRFF)

Trial & Patient Characteristics

Cancer TypeLiver
Trial TypeTreatment
Age Range18 years and older
Tumour Stream -
Cancer Stage-
Anticipated Start Date2022-06-01
Anticipated End Date2024-06-30

Participating Hospitals

HospitalRoyal Adelaide Hospital
Clinical Trial CoordinatorAnne Milton
Phone08 7074 2342
Principal InvestigatorHien Le
Recruitment StatusRecruiting